Skip to main content
Erschienen in: Pediatric Cardiology 3/2019

22.02.2019 | Case Report

Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy

verfasst von: Dorin Sumanaru, Loic Josseran, Aben Essid, Blaise Mbieleu, Isabelle Haegy, Jean Bergounioux

Erschienen in: Pediatric Cardiology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

The longer survival of patients with Duchenne muscular dystrophy due to advances in clinical care has increased the incidence of Duchenne muscular dystrophy-associated cardiomyopathy, a nearly consistent feature in the third decade of life. A 26-year-old patient with Duchenne muscular dystrophy experienced severe acute heart failure triggered by pneumonia. Levosimendan was effective in improving heart function.
Literatur
1.
Zurück zum Zitat Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271–277CrossRefPubMed Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271–277CrossRefPubMed
2.
Zurück zum Zitat Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H (1998) Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation 98:2141–2147CrossRefPubMed Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H (1998) Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation 98:2141–2147CrossRefPubMed
3.
Zurück zum Zitat Lunghetti S, Palmerini E, Urselli R et al (2011) Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure. Cardiol J 18:532–537CrossRefPubMed Lunghetti S, Palmerini E, Urselli R et al (2011) Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure. Cardiol J 18:532–537CrossRefPubMed
4.
Zurück zum Zitat Morelli A, De Castro S, Teboul JL et al (2005) Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31:638–644CrossRefPubMed Morelli A, De Castro S, Teboul JL et al (2005) Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31:638–644CrossRefPubMed
5.
Zurück zum Zitat Follath F, Cleland JG, Just H et al (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360:196–202CrossRefPubMed Follath F, Cleland JG, Just H et al (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360:196–202CrossRefPubMed
6.
Zurück zum Zitat Flevari P, Parissis JT, Leftheriotis D, Panou F, Kourea K, Kremastinos DT (2006) Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy. Am J Cardiol 98(12):1641–1645CrossRefPubMed Flevari P, Parissis JT, Leftheriotis D, Panou F, Kourea K, Kremastinos DT (2006) Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy. Am J Cardiol 98(12):1641–1645CrossRefPubMed
7.
Zurück zum Zitat Antila S, Sundberg S, Lehtonen LA (2007) Clinical pharmacology of levosimendan. Clin Pharmacokinet 2007;46(7):535–552 (Review)CrossRefPubMed Antila S, Sundberg S, Lehtonen LA (2007) Clinical pharmacology of levosimendan. Clin Pharmacokinet 2007;46(7):535–552 (Review)CrossRefPubMed
8.
Zurück zum Zitat Lilleberg J, Ylönen V, Lehtonen L, Toivonen L (2004) The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies. Scand Cardiovasc J 38(2):80–84CrossRefPubMed Lilleberg J, Ylönen V, Lehtonen L, Toivonen L (2004) The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies. Scand Cardiovasc J 38(2):80–84CrossRefPubMed
Metadaten
Titel
Levosimendan as Rescue Therapy for Acute Heart Failure in a Patient with Duchenne Muscular Dystrophy
verfasst von
Dorin Sumanaru
Loic Josseran
Aben Essid
Blaise Mbieleu
Isabelle Haegy
Jean Bergounioux
Publikationsdatum
22.02.2019
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 3/2019
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-019-02072-9

Weitere Artikel der Ausgabe 3/2019

Pediatric Cardiology 3/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.